Company Filing History:
4 out of 29 
3 out of 14 
2 out of 47 Years Active: 1990-2022
Title: Ebba Florin-Robertsson: Pioneering Innovator in Pharmaceutical Compositions
Introduction
Ebba Florin-Robertsson, a prominent inventor based in Stockholm, Sweden, has made significant contributions to the field of pharmaceuticals, particularly in developing innovative compositions for medical treatments. With a remarkable portfolio of 11 patents, her work is instrumental in advancing therapeutic options for various health conditions.
Latest Patents
Florin-Robertsson's latest patents showcase her expertise in formulating compositions that utilize anakinra, a biological product essential for managing certain inflammatory conditions. One notable invention is the "Compositions comprising anakinra," which details a formulation that includes anakinra, buffer, and optional osmolytes. This invention is specifically designed for the treatment of ophthalmic disorders. Another significant patent is for "Citrate free pharmaceutical compositions comprising anakinra," which focuses on developing compositions without sodium citrate. This formulation is intended for treating IL-1 mediated disorders and effectively alleviating nociceptive pain during treatments.
Career Highlights
Throughout her career, Ebba has worked with reputable companies known for their contributions to biotechnology and pharmaceuticals. She has held positions at Kabivitrum AB and Swedish Orphan Biovitrum AB (publ), where her innovations have fostered advancements in treatment options for patients. Her dedication and expertise in pharmaceutical development have been recognized within the industry.
Collaborations
Collaboration is key to innovation, and Florin-Robertsson has worked closely with esteemed colleagues such as Anders Strom and Bo Ahlstrand. Their combined efforts have resulted in groundbreaking research and development in the pharmaceutical sector, propelling forward the possibilities of medical treatments.
Conclusion
Ebba Florin-Robertsson continues to be an influential figure in the field of pharmaceutical innovation. Her extensive patent portfolio and collaborations reflect her commitment to enhancing treatment methodologies and improving patient care. As she advances her work, her contributions remain pivotal in the ongoing evolution of pharmaceuticals.